CV Sciences Inc. (CVSI)
OTCQB OTCQB Primary Summary
CV Sciences, Inc. (CVSI) Q3 2025 Earnings Call Prepared Remarks Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Brendan Hawkins Joseph Dowling - CEO, Secretary & Director Joerg Grasser - Chief Financial Officer Presentation Operator Greetings, and welcome to the CV Sciences Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
CV Sciences, Inc. (CVSI) Q1 2025 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q1 2025 - Earnings Conference Call May 14, 2025 4:00 PM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participants Operator Greetings, and welcome to CV Sciences' First Quarter 2025 Earnings Conference Call. At this time, participants are in a listen only mode.
CV Sciences, Inc. (CVSI) Q4 2024 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q4 2024 Earnings Conference Call March 27, 2025 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg Grasser - Chief Financial Officer Conference Call Participants Operator Greetings and welcome to the CV Sciences' Fourth Quarter and Year-End 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
CV Sciences Inc. (CVSI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has CV Sciences Inc. ever had a stock split?
CV Sciences Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Joseph D. Dowling CEO | OTCQB Exchange | US1266541028 ISIN |
| United States Country | 42 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
CV Sciences, Inc., established in San Diego, California, since its inception in 2010, stands as a significant player in the North American market for herbal supplements and hemp-based cannabidiol (CBD) products. Initially known as CannaVest Corp., the company underwent a name change to CV Sciences, Inc. in January 2016, reflecting its broader commitment to scientific innovation within the CBD industry. The company’s operations encompass the development, manufacturing, marketing, and sale of a variety of CBD-based products and it is also pioneering cannabinoids for potential medical use. It caters to various sectors of the health care market including nutraceuticals, beauty care, specialty foods, and pet products, distributing its offerings through a spectrum of channels including its own websites, select distributors, brick-and-mortar retailers, and certain e-tailers.
Products and Services
- PlusCBD: A flagship product line from CV Sciences that offers an extensive range of CBD-based health and wellness supplements. These products are designed to support overall well-being.
- ProCBD: Catered towards those seeking enhanced benefits from their CBD use, ProCBD products are formulated to target specific wellness goals and concerns, offering a potent alternative within the CBD market.
- HappyLane: This range focuses on delivering 0% THC CBD products, ensuring consumers can enjoy the benefits of CBD without the psychoactive effects of THC. HappyLane is marketed towards individuals conscious about THC intake but eager to explore CBD’s potential.
- PlusCBD Pet: Recognizing the growing demand for pet wellness solutions, CV Sciences extends its CBD expertise to our furry friends. PlusCBD Pet products are designed to offer pets the same quality of CBD support that humans enjoy.
- CVSI-007: Beyond their consumer products, CV Sciences is invested in developing cannabinoids for therapeutic purposes. CVSI-007 is one such endeavor, combining CBD and nicotine in an innovative formulation intended to treat smokeless tobacco use and addiction, marking the company’s foray into addressing global health challenges through cannabinoid solutions.
Contact Information
